Sign in
Taking people in United StatesNo phase

Depth Electrode Cortical Reverberation Monitoring After Traumatic Brain Injury

Key facts

Who runs it
Samuel Cramer
Where
Minneapolis, United StatesSee the site
Trial code
Status
Recruiting
People taking part
15 people, planned
Started
1 May 2026
Expected to end
30 Jan 2028
Type of study
Interventional
Treatments tested
  • A multi-contact depth electrode
Record updated
25 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (8)Hide the full registry criteria

Who can take part

  • 18 years or older
  • Consenting party must be able to provide written consent in English
  • Patient recommended to undergo EVD placement for the monitoring and possible treatment of ICP after TBI

Who cannot take part

  • Known systemic infection
  • Contaminated scalp lacerations
  • Non-English speaking
  • Fixed, uncorrectable coagulopathy
  • Pregnant, minors, or wards of the state

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Traumatic brain injury

This trial is currently available in United States.

  • Hennepin Healthcare Research InstituteMinneapolis, United StatesContact: Samuel Cramer, MD, PhDTaking people

About the trial

What the trial wants to find out

This is a preliminary, prospective interventional feasibility study to investigate the use of cortical reverberation (CR) monitoring in patients with traumatic brain injury (TBI) requiring a clinically indicated external ventricular drain (EVD) placement.

The group in the trial

  • TBI PatientsOther group

    This is a single-arm study.

    Treatment: A multi-contact depth electrode

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07842458, who can take part
Record updated
25 September 2026